Literature DB >> 7741194

Levels of soluble ICAM-1 in atopic dermatitis. A new marker for monitoring the clinical activity?

B Wüthrich1, H Joller-Jemelka, M K Kägi.   

Abstract

Levels of soluble intercellular adhesion molecule-1 (sICAM-1) were measured in sera from patients with an acute exacerbation of their atopic dermatitis (AD) (n = 16) on admission to and discharge from our department of dermatology. At admission, the sICAM-1 levels in sera from patients with AD were slightly higher than those of the blood donors (n = 100) and dropped at discharge significantly (P = 0.014) after improvement of the skin conditions. Therefore, sICAM-1 may be, together with soluble interleukin-2 receptor (sIL-2), eosinophilic cationic protein (ECP), and CD14, another marker for monitoring AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7741194     DOI: 10.1111/j.1398-9995.1995.tb02488.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  3 in total

1.  Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome.

Authors:  J Krejsek; R Slezák; O Kopecky; V Derner; C Andrys
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

2.  Modulation of Immune Functions by Foods.

Authors:  Shuichi Kaminogawa; Masanobu Nanno
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-06       Impact factor: 2.629

3.  VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model.

Authors:  Lin Chen; Shao-xia Lin; Sanober Amin; Lut Overbergh; Giacomo Maggiolino; Lawrence S Chan
Journal:  Immunol Cell Biol       Date:  2010-01-12       Impact factor: 5.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.